Company intelligence / Profile preview
Serpin Pharma
Manassas, Virginia, United Statesserpinpharma.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
01
Overview
In AMI, a single SP16 injection preserved heart function, reduced infarcts, and decreased biomarkers of cardiac injury. SP16 is currently undergoing pre-clinical and clinical trials for a broad span of orphan, chronic, and acute indications.
- Therapeutic areas
- GastroenterologyImmunologyCardiovascularDermatology
- Modalities
- Synthetic peptideTherapeutic protein
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
The Estée Lauder Companies (announced February 26, 2025)
Beyond the preview
Go deeper on Serpin Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serpin Pharma.